Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®*, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
WAN-IFRA announced the 2024 Digital Media Americas Awards winners in Panama City as part of its annual Digital Media LAT…
The US trade magazine "Healthcare Tech Outlook" recently named ibidi GmbH one of the ten best European manufacturers of…
Herzlich willkommen zu den Apotheker-Nachrichten, Ihrem verlässlichen Begleiter durch die vielschichtige Welt der Pharma…
In der Session „New Drugs on the Horizon“ präsentiert Bayer präklinische und klinische Bildgebungsdaten zu Actinium-225…
Fast Track designation awarded by the FDA serves as an external validation of the potential of NOX-A12 for unmet need in…
Entdecken Sie die neuesten Entwicklungen und Herausforderungen im deutschen Apothekenwesen! Von den brisanten Diskussion…
Gold is not only an excellent means of preserving value for investors but is also becoming increasingly important in med…
In der deutschen Apothekenlandschaft herrscht derzeit eine Phase der finanziellen Unsicherheit, verstärkt durch die AvP-…
ProteinQure, the leading startup in the computational design of peptide drugs, announces a significant breakthrough in t…